HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer

Pancreatic cancer is intractable due to early progression and resistance to conventional therapy. Dense fibrotic stroma, known as desmoplasia, is a characteristic feature of pancreatic cancer, and develops through the interactions between pancreatic cancer cells and stromal cells, including pancreat...

Full description

Bibliographic Details
Main Authors: Shin Hamada, Ryotaro Matsumoto, Atsushi Masamune
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/2/411
_version_ 1797495303393247232
author Shin Hamada
Ryotaro Matsumoto
Atsushi Masamune
author_facet Shin Hamada
Ryotaro Matsumoto
Atsushi Masamune
author_sort Shin Hamada
collection DOAJ
description Pancreatic cancer is intractable due to early progression and resistance to conventional therapy. Dense fibrotic stroma, known as desmoplasia, is a characteristic feature of pancreatic cancer, and develops through the interactions between pancreatic cancer cells and stromal cells, including pancreatic stellate cells. Dense stroma forms harsh tumor microenvironments characterized by hypoxia, few nutrients, and oxidative stress. Pancreatic cancer cells as well as pancreatic stellate cells survive in the harsh microenvironments through the altered expression of signaling molecules, transporters, and metabolic enzymes governed by various stress response mechanisms. Hypoxia inducible factor-1 and KEAP1-NRF2, stress response mechanisms for hypoxia and oxidative stress, respectively, contribute to the aggressive behaviors of pancreatic cancer. These key molecules for stress response mechanisms are activated, both in pancreatic cancer cells and in pancreatic stellate cells. Both factors are involved in the mutual activation of cancer cells and stellate cells, by inducing cancer-promoting signals and their mediators. Therapeutic interventions targeting these pathways are promising approaches for novel therapies. In this review, we summarize the roles of stress response mechanisms, focusing on hypoxia inducible factor-1 and KEAP1-NRF2, in pancreatic cancer. In addition, we discuss the potential of targeting these molecules for the treatment of pancreatic cancer.
first_indexed 2024-03-10T01:45:57Z
format Article
id doaj.art-247d085e5d62456da60fea652a15b6c2
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T01:45:57Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-247d085e5d62456da60fea652a15b6c22023-11-23T13:14:31ZengMDPI AGCancers2072-66942022-01-0114241110.3390/cancers14020411HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic CancerShin Hamada0Ryotaro Matsumoto1Atsushi Masamune2Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai 980-8574, JapanDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai 980-8574, JapanDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai 980-8574, JapanPancreatic cancer is intractable due to early progression and resistance to conventional therapy. Dense fibrotic stroma, known as desmoplasia, is a characteristic feature of pancreatic cancer, and develops through the interactions between pancreatic cancer cells and stromal cells, including pancreatic stellate cells. Dense stroma forms harsh tumor microenvironments characterized by hypoxia, few nutrients, and oxidative stress. Pancreatic cancer cells as well as pancreatic stellate cells survive in the harsh microenvironments through the altered expression of signaling molecules, transporters, and metabolic enzymes governed by various stress response mechanisms. Hypoxia inducible factor-1 and KEAP1-NRF2, stress response mechanisms for hypoxia and oxidative stress, respectively, contribute to the aggressive behaviors of pancreatic cancer. These key molecules for stress response mechanisms are activated, both in pancreatic cancer cells and in pancreatic stellate cells. Both factors are involved in the mutual activation of cancer cells and stellate cells, by inducing cancer-promoting signals and their mediators. Therapeutic interventions targeting these pathways are promising approaches for novel therapies. In this review, we summarize the roles of stress response mechanisms, focusing on hypoxia inducible factor-1 and KEAP1-NRF2, in pancreatic cancer. In addition, we discuss the potential of targeting these molecules for the treatment of pancreatic cancer.https://www.mdpi.com/2072-6694/14/2/411HIF-1KEAP1NRF2hypoxiamicroenvironmentoxidative stress
spellingShingle Shin Hamada
Ryotaro Matsumoto
Atsushi Masamune
HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer
Cancers
HIF-1
KEAP1
NRF2
hypoxia
microenvironment
oxidative stress
title HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer
title_full HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer
title_fullStr HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer
title_full_unstemmed HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer
title_short HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer
title_sort hif 1 and nrf2 key molecules for malignant phenotypes of pancreatic cancer
topic HIF-1
KEAP1
NRF2
hypoxia
microenvironment
oxidative stress
url https://www.mdpi.com/2072-6694/14/2/411
work_keys_str_mv AT shinhamada hif1andnrf2keymoleculesformalignantphenotypesofpancreaticcancer
AT ryotaromatsumoto hif1andnrf2keymoleculesformalignantphenotypesofpancreaticcancer
AT atsushimasamune hif1andnrf2keymoleculesformalignantphenotypesofpancreaticcancer